SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-007778
Filing Date
2013-07-25
Accepted
2013-07-25 14:43:33
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2216033z10-q.htm 10-Q 365132
2 EX-3.1 a2216033zex-3_1.htm EX-3.1 79486
3 EX-31.1 a2216033zex-31_1.htm EX-31.1 14132
4 EX-32.1 a2216033zex-32_1.htm EX-32.1 7765
11 G717126.JPG g717126.jpg GRAPHIC 10065
  Complete submission text file 0001047469-13-007778.txt   5105643

Data Files

Seq Description Document Type Size
5 EX-101.INS nutr-20130630.xml EX-101.INS 336565
6 EX-101.SCH nutr-20130630.xsd EX-101.SCH 44795
7 EX-101.CAL nutr-20130630_cal.xml EX-101.CAL 62608
8 EX-101.DEF nutr-20130630_def.xml EX-101.DEF 141255
9 EX-101.LAB nutr-20130630_lab.xml EX-101.LAB 783101
10 EX-101.PRE nutr-20130630_pre.xml EX-101.PRE 369318
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 13986018
SIC: 2833 Medicinal Chemicals & Botanical Products